The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...
Ty Pendlebury has worked at CNET since 2006. He lives in New York City where he writes about TVs and home entertainment. Expertise Ty has worked for radio, print, and online publications, and has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback